Institutional investors purchased a net $9.9 million shares of AZN during the quarter ended December 2016 and now own 12.69% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 9.2 Million shares of AstraZeneca
PRIMECAP MANAGEMENT CO. Bought 8.7 Million shares of AstraZeneca
DODGE & COX Bought 7.4 Million shares of AstraZeneca